Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease

go back to reference Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–2038PubMedCrossRef Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–2038PubMedCrossRef

go back to reference Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D (2010) Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol 99:715–721PubMedCrossRef Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D (2010) Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol 99:715–721PubMedCrossRef

go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef

go back to reference Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler–Soler J, Ohrvik J (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880–1890PubMedCrossRef Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler–Soler J, Ohrvik J (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880–1890PubMedCrossRef

go back to reference Hu DY, Pan CY, Yu JM (2006) The relationship between coronary artery disease and abnormal glucose regulation in China: The China Heart Survey. Eur Heart J 27:2573–2579PubMedCrossRef Hu DY, Pan CY, Yu JM (2006) The relationship between coronary artery disease and abnormal glucose regulation in China: The China Heart Survey. Eur Heart J 27:2573–2579PubMedCrossRef

go back to reference Wascher TC, Sourij H, Roth M, Dittrich P (2004) Prevalence of pathological glucose metabolism in patients undergoing elective coronary angiography. Atherosclerosis 176:419–421PubMedCrossRef Wascher TC, Sourij H, Roth M, Dittrich P (2004) Prevalence of pathological glucose metabolism in patients undergoing elective coronary angiography. Atherosclerosis 176:419–421PubMedCrossRef

go back to reference American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRef American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRef

go back to reference International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef

go back to reference World Health Organization and International Diabetes Federation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Organization, Geneva World Health Organization and International Diabetes Federation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Organization, Geneva

go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 15:539–553CrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 15:539–553CrossRef

go back to reference Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and prediabetes with proposed A1c-based diagnostic criteria. Diabetes Care 33:2184–2189PubMedCrossRef Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and prediabetes with proposed A1c-based diagnostic criteria. Diabetes Care 33:2184–2189PubMedCrossRef

go back to reference Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM (2010) Hemoglobin A1c between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the insulin resistance atherosclerosis study (IRAS). Diabetes Care 33:2104–2109PubMedCrossRef Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM (2010) Hemoglobin A1c between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the insulin resistance atherosclerosis study (IRAS). Diabetes Care 33:2104–2109PubMedCrossRef

go back to reference Kramer CK, Araneta MR, Barrett-Connor E (2010) A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 33:101–103PubMedCrossRef Kramer CK, Araneta MR, Barrett-Connor E (2010) A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 33:101–103PubMedCrossRef

go back to reference Buell C, Kermah D, Davidson MB (2007) Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 30:2233–2235PubMedCrossRef Buell C, Kermah D, Davidson MB (2007) Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 30:2233–2235PubMedCrossRef

go back to reference van’t Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM (2010) Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 33:61–66CrossRef van’t Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM (2010) Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 33:61–66CrossRef

go back to reference Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRef Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRef

go back to reference Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E (2010) Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg 89:1482–1487PubMedCrossRef Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E (2010) Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg 89:1482–1487PubMedCrossRef

go back to reference Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340:c2249PubMedCrossRef Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340:c2249PubMedCrossRef

go back to reference Boavida JM, Gardete-Correia L, Massano-Cardoso S, Mesquita C, Raposo JF (2010) Hemoglobin A1c in a population with pre-diabetes, diagnosed and previously undiagnosed diabetes. Diabetologia 53:S87 Boavida JM, Gardete-Correia L, Massano-Cardoso S, Mesquita C, Raposo JF (2010) Hemoglobin A1c in a population with pre-diabetes, diagnosed and previously undiagnosed diabetes. Diabetologia 53:S87

go back to reference Cosson E, Nguyen M, Hamo Tchatchouang E, Banu I, Chiheb S, Valensi P (2010) Diagnosis of abnormal glucose levels in patients at high risk for the development of diabetes: a comparison of the oral glucose tolerance test and measurement of HbA1c following the American Diabetes Association recommendations 2010. Diabetologia 53:S87 Cosson E, Nguyen M, Hamo Tchatchouang E, Banu I, Chiheb S, Valensi P (2010) Diagnosis of abnormal glucose levels in patients at high risk for the development of diabetes: a comparison of the oral glucose tolerance test and measurement of HbA1c following the American Diabetes Association recommendations 2010. Diabetologia 53:S87

go back to reference Delgado E, De la Hera JM, Lozano I, Hernandez E, Vegas JM, Fernandez-Cimadevilla C, Torres F, Carro A, Bayon J, Garcia-Ruiz JM, Avanzas P (2010) Detection of diabetes in coronary artery disease: oral glucose tolerance test or glycated haemoglobin and fasting plasma glucose? Diabetologia 53:S159 Delgado E, De la Hera JM, Lozano I, Hernandez E, Vegas JM, Fernandez-Cimadevilla C, Torres F, Carro A, Bayon J, Garcia-Ruiz JM, Avanzas P (2010) Detection of diabetes in coronary artery disease: oral glucose tolerance test or glycated haemoglobin and fasting plasma glucose? Diabetologia 53:S159

go back to reference Koehler C, Henkel E, Schaper F, Hanefeld M (2010) The HbA1c cut points for detecting type 2 diabetes and prediabetes in a risk population—is this the right way? Diabetologia 53:S158 Koehler C, Henkel E, Schaper F, Hanefeld M (2010) The HbA1c cut points for detecting type 2 diabetes and prediabetes in a risk population—is this the right way? Diabetologia 53:S158

go back to reference Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H (2010) Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J 31(13):1583–1590PubMedCrossRef Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC, Drexel H (2010) Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. Eur Heart J 31(13):1583–1590PubMedCrossRef

go back to reference Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med 19:708–723CrossRef Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med 19:708–723CrossRef

go back to reference Preiss D, Welsh P, Murray HM, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 31:1230–1236PubMedCrossRef Preiss D, Welsh P, Murray HM, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N (2010) Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 31:1230–1236PubMedCrossRef

go back to reference Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136PubMedCrossRef Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88–136PubMedCrossRef

go back to reference Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077PubMedCrossRef Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077PubMedCrossRef

go back to reference Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009) Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction—a cohort study on 224 patients. Cardiovasc Diabetol 8:6PubMedCrossRef Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009) Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction—a cohort study on 224 patients. Cardiovasc Diabetol 8:6PubMedCrossRef

go back to reference Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144PubMedCrossRef Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144PubMedCrossRef